Treatment of canine cutaneous epitheliotropic T-cell lymphoma with oclacitinib: a case report.

Jeylan Aslan, Michael A Shipstone, Louise M Sullivan

Veterinary dermatology 2021 Aug

filter terms:

Canine cutaneous epitheliotropic T-cell lymphoma (CETL) is associated with a poor prognosis and without consistently beneficial treatment options. This case report describes a 9-year-old Staffordshire bull terrier with CETL treated with oclacitinib (0.7 mg/kg twice daily), resulting in partial remission that was maintained for three months. Further studies are warranted. © 2021 the European Society of Veterinary Dermatology and the American College of Veterinary Dermatology.

Citation

Jeylan Aslan, Michael A Shipstone, Louise M Sullivan. Treatment of canine cutaneous epitheliotropic T-cell lymphoma with oclacitinib: a case report. Veterinary dermatology. 2021 Aug;32(4):398-e113